See this page online at: http://www.biotechfocus.com/2011Issue9
 |
Sign up for your subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
Readers Respond
By Shawn Lawrence
Readers respond and share their views on the industry's strengths and offer ways to improve Canadian Biotech. |
|
The Promise of Innovation Procurement
By Gabriela Prada
The Conference Board of Canada discusses its report on innovation procurement and what it means for the health care and biotechnology sectors. |
|
An Evolution Is Underway
By Pierre Meulien
Genome Canada president and CEO Dr. Pierre Meulien discusses genomics as a building block of science and industry in Canada. |
|
National Biotech Week
Compiled by Biotechnology Focus
Biotechnology Focus goes one-on-one with BIOTECanada president and CEO Peter Brenders on the eve of the event now in its eighth year. |
|
Saskatchewan Bioscience: Capturing value from innovation
By Ag-West Bio
With an enviable mix of capacity spread throughout industry, government and universities, Saskatchewan's bioeconomy is poised for sustainable long term growth. |
|
A Path Back to Success: How Canadian Biotech can regain lost ground and access capital
By Paul Karamanoukian
Ernst & Young Canada life sciences industry leader Paul Karamanoukian believes the Canadian biotech industry must return to business fundamentals and reinvent itself to capitalize on the opportunities born from the changing health care system. |
|
The Canadian biotechnology public policy agenda
By Jeffrey Graham, Chantal Saunders and Beverley Moore
With a new federal government in Ottawa and new governments to be installed at the provincial level in a number of jurisdictions over the next couple of years, starting with Ontario later this fall, there is, perhaps, a new opportunity to make changes that have a positive impact on the public policy framework relevant to the sector in Canada. |
|
Give something back: Get Involved
By Brad Thompson
There is no doubt that the Canadian biotechnology industry is experiencing sustainability issues in this challenging economic environment. In June 2011, Ernst & Young published a report entitled Beyond borders: Global biotechnology report 2011 explaining that Canadian biotech companies did not capture their share of the global capital raised in 2010, while private biotech financing in Canada is at its lowest level in 10 years. |
